Table 2.
The relationship between miR-21 expression and cliniccopathological features of lung cancer patients
| Clinicopathological features | Cases (n=30) | miR-21 expression | P value | |
|---|---|---|---|---|
| High | Low | |||
| Age (years) | 0.7047 | |||
| > 60 | 23 | 12 | 11 | |
| ≤ 60 | 34 | 16 | 18 | |
| Gender | 0.1885 | |||
| Male | 29 | 17 | 12 | |
| Female | 28 | 11 | 17 | |
| Tumor size (cm) | 0.0030 | |||
| ≥ 3.0 | 33 | 22 | 11 | |
| < 3.0 | 24 | 6 | 18 | |
| TNM stage | 0.0277 | |||
| I–II | 21 | 6 | 15 | |
| IIIa | 36 | 22 | 14 | |
| Smoking history | 0.0167 | |||
| Smokers | 31 | 20 | 11 | |
| Non-mokers | 26 | 8 | 18 | |
| Lymph node metastasis | 0.0074 | |||
| Positive | 24 | 17 | 7 | |
| Negative | 33 | 11 | 22 | |
| Histological tumor type | 0.2828 | |||
| Squamous cell carcinoma | 19 | 11 | 8 | |
| Adenocarcinoma | 21 | 12 | 9 | |
| Small cell lung cancer | 13 | 4 | 9 | |
| Large cell lung cancer | 4 | 1 | 3 | |